Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

CureVac N.V. (CVAC) had Revenue of $63.28M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$63.28M
Net Income	$319.38M
Cost of Goods Sold	$0.44M
Gross Profit	$62.84M
Operating Expenses	$-299.32M
Operating Income	$362.60M
Non-Operating Income/Expense	$-3.07M
Pre-Tax Income	$359.53M
Normalized Pre-Tax Income	$359.53M
Income after Taxes	$319.38M
Income from Continuous Operations	$319.38M
Consolidated Net Income/Loss	$319.38M
Normalized Income after Taxes	$319.38M
EBIT	$362.60M
EBITDA	$368.00M
Weighted-Average Shares Outstanding (Basic)	225.80M
Weighted-Average Shares Outstanding (Diluted)	225.80M
Earnings per Share (EPS) (Basic)	$1.41
Earnings per Share (EPS) (Diluted)	$1.41
Balance Sheet Financials
Current Assets	$1.02B
Property, Plant, and Equipment	$233.64M
Long-Term Assets	$310.35M
Total Assets	$1.33B
Current Liabilities	$276.06M
Long-Term Debt	$35.42M
Long-Term Liabilities	$36.49M
Total Liabilities	$312.55M
Common Equity	$1.02B
Tangible Shareholders Equity	$989.53M
Shareholders Equity	$1.02B
Common Shares Outstanding	--
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-62.62M
Cash Flow from Investing Activities	$-2.79M
Cash Flow from Financial Activities	$-4.57M
Beginning Cash	$563.12M
End Cash	$486.37M
Increase/Decrease in Cash	$-76.75M
Stock-Based Compensation	$4.85M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.70
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.03
Debt to Equity Ratio	0.04
Gross Margin	99.31%
Operating Margin	573.04%
EBIT Margin	573.04%
EBITDA Margin	--
Pre-Tax Profit Margin	568.18%
Profit Margin	504.73%
Free Cash Flow	$-64.32M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.05
Inventory Turnover	0.69
Receiveable Turnover	1.98
Days Sales in Receivables	45.49
Return on Equity	31.36%
Return on Tangible Equity	32.28%
Return on Assets	24.00%
Return on Investments	30.31%
Book Value Per Share	--
Free Cash Flow per Share	$-0.28
Operating Cash Flow per Share	$-0.28

Data from Zacks Investment Research, Inc.